Published:
Psilocybe Natalensis
"Natal Super Strength"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/Natalensis_new-800x450.webp)
Scientific Classification
About
Psilocybe natalensis, commonly known as Natal Super Strength, is a potent, lesser-known species of psilocybin mushroom endemic to South Africa. Often compared to Psilocybe cubensis in terms of appearance and psychoactive profile, it is celebrated for its fast onset, intense visuals, and deep emotional and spiritual impact—which earned it the “super strength” moniker among cultivators and psychonauts.
History
Discovered in the Natal region of South Africa, P. natalensis was described scientifically in the 1990s. Despite being geographically isolated, its reputation has grown in the psychedelic community due to reports of smooth, euphoric, and long-lasting experiences. It thrives in grasslands and open areas, often during the rainy season.
Its distinct genetic traits, resilience, and strength of effects have made it a subject of growing interest for both recreational and therapeutic use, particularly in microdosing and spiritual practices.
Overview
Visually similar to P. cubensis, P. natalensis has a slightly thicker stipe, often with a bluish hue at the base, and a cap that ranges from cream to golden brown. It bruises blue when damaged due to psilocybin oxidation. Its spore print is purple-brown, and it produces medium-sized fruiting bodies with a rapid growth cycle.
Effects are typically characterized by powerful euphoria, vivid geometric patterns, deep introspection, and mystical states of consciousness. Many users report that it is more consistent and emotionally forgiving than other high-potency species, making it suitable for inner work and connection.
Physical Characteristics
Caps:
Conic to convex, maturing to broadly convex or flat, smooth, with a distinctive umbo
Gills:
Adnate to adnexed, close, ranging from light brown to dark purple-brown with age
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Pharmacology
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Possible Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Grow at Home
Start your cultivation journey with quality grow kits from verified vendors
Chemical Constituents
Medicinal Chemistry
Mushroom Ratings
4.8
(4)
Based on 4 Reviews
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
01/29/2025
Zaky J
01/29/2025
Javier Villarreal
07/26/2024
Josh Shearer
2 people found this helpful
References
- Qutaibi, M. A. & Kagne , S. R. (2024). Exploring the Phytochemical Compositions, Antioxidant Activity, and Nutritional Potentials of Edible and Medicinal Mushrooms. .
- Sekssaoui, M. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?. .
- Ley, L. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. .
- Bae, S. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. .
- Schindler, E. (2022 ). Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. .
- Barrett, F. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. .
- Desai, S. (2022). Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study. .
- Rucker, J. (2021). Psilocybin: From Serendipity to Credibility?. .
- Schindler, E. (2021). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. .
- Raval, N. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. .